Brief: Usana Health Sciences Reports Second Quarter Net Sales Of $238 Million And Diluted EPS Of $0.89
July 25 (Reuters) - USANA Health Sciences Inc USNA.N :
* USANA HEALTH SCIENCES REPORTS SECOND QUARTER NET SALES OF
$238
MILLION AND DILUTED EPS OF $0.89
* USANA HEALTH SCIENCES INC - RAISING LOWER END OF ITS NET
SALES
AND EARNINGS PER SHARE OUTLOOK FOR FISCAL YEAR 2023
* USANA HEALTH SCIENCES INC - SEES FY DILUTED EPS $2.65 -
$3.30
* USANA HEALTH SCIENCES INC - SEES FY CONSOLIDATED NET SALES
$900
- $950 MILLION
Source text for Eikon: ID:nBwQc4sMa
Further company coverage: USNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview